BioAdaptives, Inc.
BDPT
$0.0006
$0.000120.00%
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -53.85% | 578.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -53.85% | 578.26% | |||
| Cost of Revenue | -59.09% | 1,275.00% | |||
| Gross Profit | -42.55% | 213.33% | |||
| SG&A Expenses | 27.20% | 4.23% | |||
| Depreciation & Amortization | -128.72% | 5,271.43% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -36.05% | 85.08% | |||
| Operating Income | 32.97% | -64.94% | |||
| Income Before Tax | -1,948.09% | 90.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,948.09% | 90.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,948.09% | 90.90% | |||
| EBIT | 32.97% | -64.94% | |||
| EBITDA | -0.18% | 1.27% | |||
| EPS Basic | -- | 100.00% | |||
| Normalized Basic EPS | -400.00% | 150.00% | |||
| EPS Diluted | -- | 100.00% | |||
| Normalized Diluted EPS | -400.00% | 150.00% | |||
| Average Basic Shares Outstanding | 7.93% | 65.26% | |||
| Average Diluted Shares Outstanding | 7.93% | 65.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
